GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lotus Pharmaceutical Co Ltd (TPE:1795) » Definitions » Total Debt per Share

Lotus Pharmaceutical Co (TPE:1795) Total Debt per Share : NT$46.96 (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Lotus Pharmaceutical Co Total Debt per Share?

NT$46.96 (As of Mar. 2025)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Lotus Pharmaceutical Co's Total Debt Per Share for the quarter that ended in Mar. 2025 was NT$46.96.

Lotus Pharmaceutical Co Total Debt per Share Historical Data

The historical data trend for Lotus Pharmaceutical Co's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotus Pharmaceutical Co Total Debt per Share Chart

Lotus Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.85 24.36 34.03 43.80 51.50

Lotus Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.01 40.25 46.94 51.50 46.96

Lotus Pharmaceutical Co Total Debt per Share Calculation

Lotus Pharmaceutical Co's Total Debt Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(8,578+5,089)/265
=51.50

Lotus Pharmaceutical Co's Total Debt Per Share for the quarter that ended in Mar. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(8,578+3,822)/264
=46.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Pharmaceutical Co Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Lotus Pharmaceutical Co's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Lotus Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lotus Pharmaceutical Co Ltd (TPE:1795) » Definitions » Total Debt per Share
Comparable Companies
TPE:6472 ROCO:4123 TPE:1707 ROCO:4105 TPE:3705 ROCO:4114 TPE:1789 ROCO:6620 TPE:1720 ROCO:6576 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Song Ren Road, 17th Floor, No. 277, Xin Yi District, Taipei, TWN, 110
Website
https://www.lotuspharm.com
Lotus Pharmaceutical Co Ltd is engaged in the healthcare sector. The only reportable segment of the company is the Pharmaceuticals business segment, which engages mainly in the research and development, manufacturing and sales of pharmaceutical products. It has a geographic presence in the United States, Malta, Taiwan, and Others.

Lotus Pharmaceutical Co Headlines

No Headlines